134 related articles for article (PubMed ID: 34371167)
1. Sequential enzyme-activated macrotheranostic probe for selective tumor mitochondria targeting.
Ma D; Zong Q; Du Y; Yu F; Xiao X; Sun R; Guo Y; Wei X; Yuan Y
Acta Biomater; 2021 Nov; 135():628-637. PubMed ID: 34371167
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-targeted cancer therapy using a light-up probe with aggregation-induced-emission characteristics.
Hu Q; Gao M; Feng G; Liu B
Angew Chem Int Ed Engl; 2014 Dec; 53(51):14225-9. PubMed ID: 25318447
[TBL] [Abstract][Full Text] [Related]
3. Macrotheranostic Probe with Disease-Activated Near-Infrared Fluorescence, Photoacoustic, and Photothermal Signals for Imaging-Guided Therapy.
Zhen X; Zhang J; Huang J; Xie C; Miao Q; Pu K
Angew Chem Int Ed Engl; 2018 Jun; 57(26):7804-7808. PubMed ID: 29665259
[TBL] [Abstract][Full Text] [Related]
4. Dual-locking nanoprobe based on hemicyanine for orthogonal stimuli-triggered precise cancer imaging and therapy.
Zong Q; Zheng R; Xiao X; Jiang M; Li J; Yuan Y
J Control Release; 2021 Oct; 338():307-315. PubMed ID: 34454962
[TBL] [Abstract][Full Text] [Related]
5. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent Coumarin-Artemisinin Conjugates as Mitochondria-Targeting Theranostic Probes for Enhanced Anticancer Activities.
Zhang X; Ba Q; Gu Z; Guo D; Zhou Y; Xu Y; Wang H; Ye D; Liu H
Chemistry; 2015 Nov; 21(48):17415-21. PubMed ID: 26458147
[TBL] [Abstract][Full Text] [Related]
7. An NIR-Fluorophore-Based Theranostic for Selective Initiation of Tumor Pyroptosis-Induced Immunotherapy.
Wang K; Xiao X; Jiang M; Li J; Zhou J; Yuan Y
Small; 2021 Sep; 17(36):e2102610. PubMed ID: 34323375
[TBL] [Abstract][Full Text] [Related]
8. Dual Channel Activatable Cyanine Dye for Mitochondrial Imaging and Mitochondria-Targeted Cancer Theranostics.
Pan GY; Jia HR; Zhu YX; Wang RH; Wu FG; Chen Z
ACS Biomater Sci Eng; 2017 Dec; 3(12):3596-3606. PubMed ID: 33445394
[TBL] [Abstract][Full Text] [Related]
9. TME-targeting theranostic agent uses NIR tracking for tumor diagnosis and surgical resection and acts as chemotherapeutic showing enhanced efficiency and minimal toxicity.
Xu Z; Qian J; Meng C; Liu Y; Ding Q; Wu H; Li P; Ran F; Liu GQ; Wang Y; Ling Y
Theranostics; 2022; 12(6):2535-2548. PubMed ID: 35401826
[No Abstract] [Full Text] [Related]
10. Noncovalent Theranostic Prodrug for Hypoxia-Activated Drug Delivery and Real-Time Tracking.
Zhao XB; Gao K; Shi YP
Anal Chem; 2021 Nov; 93(45):15080-15087. PubMed ID: 34743509
[TBL] [Abstract][Full Text] [Related]
11. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
Tang C; Du Y; Liang Q; Cheng Z; Tian J
Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
[TBL] [Abstract][Full Text] [Related]
12. Dual-Mode Imaging Guided Multifunctional Theranosomes with Mitochondria Targeting for Photothermally Controlled and Enhanced Photodynamic Therapy in Vitro and in Vivo.
Wang S; Guo F; Ji Y; Yu M; Wang J; Li N
Mol Pharm; 2018 Aug; 15(8):3318-3331. PubMed ID: 29975536
[TBL] [Abstract][Full Text] [Related]
13. A sequential targeting nanoplatform for anaplastic thyroid carcinoma theranostics.
Wang Q; Sui G; Wu X; Teng D; Zhu L; Guan S; Ran H; Wang Z; Wang H
Acta Biomater; 2020 Jan; 102():367-383. PubMed ID: 31778831
[TBL] [Abstract][Full Text] [Related]
14. A novel NIR fluorescent probe inhibits melanoma progression through apoptosis and ERK/DRP1-mediated mitochondrial fission.
He Q; Li C; Ou Y; Pan Y; Yang X; Wang J; Liao H; Xiong X; Liu L; Sun C
Bioorg Chem; 2024 Apr; 145():107218. PubMed ID: 38377820
[TBL] [Abstract][Full Text] [Related]
15. A pH-Activatable nanoparticle for dual-stage precisely mitochondria-targeted photodynamic anticancer therapy.
Qi T; Chen B; Wang Z; Du H; Liu D; Yin Q; Liu B; Zhang Q; Wang Y
Biomaterials; 2019 Aug; 213():119219. PubMed ID: 31132647
[TBL] [Abstract][Full Text] [Related]
16. Sulfenic Acid-Mediated on-Site-Specific Immobilization of Mitochondrial-Targeted NIR Fluorescent Probe for Prolonged Tumor Imaging.
Gao Y; Sun R; Zhao M; Ding J; Wang A; Ye S; Zhang Y; Mao Q; Xie W; Ma G; Shi H
Anal Chem; 2020 May; 92(10):6977-6983. PubMed ID: 32314575
[TBL] [Abstract][Full Text] [Related]
17. Photoactivatable Sequential Destruction of Multiorganelles for Cancer Therapy.
Pan W; Shao H; Ma L; Tong X; Zhang Z; Li Q; Yang X; Liu K; Gao M; Wang Y
ACS Appl Mater Interfaces; 2023 Aug; 15(31):37121-37129. PubMed ID: 37523306
[TBL] [Abstract][Full Text] [Related]
18. A Near-Infrared Triggered Nanophotosensitizer Inducing Domino Effect on Mitochondrial Reactive Oxygen Species Burst for Cancer Therapy.
Yu Z; Sun Q; Pan W; Li N; Tang B
ACS Nano; 2015 Nov; 9(11):11064-74. PubMed ID: 26456218
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial-targeted near-infrared fluorescence probe for selective detection of fluoride ions in living cells.
Xu X; Chen W; Yang M; Liu XJ; Wang F; Yu RQ; Jiang JH
Talanta; 2019 Nov; 204():655-662. PubMed ID: 31357349
[TBL] [Abstract][Full Text] [Related]
20. High performance one-for-all phototheranostics: NIR-II fluorescence imaging guided mitochondria-targeting phototherapy with a single-dose injection and 808 nm laser irradiation.
Wang Q; Xu J; Geng R; Cai J; Li J; Xie C; Tang W; Shen Q; Huang W; Fan Q
Biomaterials; 2020 Feb; 231():119671. PubMed ID: 31855624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
